Registry for the EVolution Of LUng cancer Therapy Implementation and Outcomes Now

Trial Identifier: D133FR00110
Sponsor: AstraZeneca
NCTID:: NCT02835599
Start Date: November 2016
Primary Completion Date: April 2017
Study Completion Date: April 2017
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Monterey, CA, US
US, CA Santa Rosa, CA, US
US, CO Colorado Springs, CO, US
US, CO Denver, CO, US
US, IL Chicago, IL, US
US, IL Urbana, IL, US
US, MI Southfield, MI, US
US, MN Duluth, MN, US
US, MN Rochester, MN, US
US, MS Jackson, MS, US
US, NE Omaha, NE, US
US, SC Rock Hill, SC, US
US, TN Germantown, TN, US
US, VA Newport News, VA, US
US, WA Tacoma, WA, US